New Results
Repurposing clemastine to target glioblastoma cell stemness
View ORCID ProfileMichael A. Sun, Rui Yang, View ORCID ProfileHeng Liu, View ORCID ProfileWenzhe Wang, Xiao Song, Bo Hu, Nathan Reynolds, Kristen Roso, View ORCID ProfileLee H. Chen, Paula K. Greer, Stephen T. Keir, View ORCID ProfileRoger E. McLendon, Shi-Yuan Cheng, View ORCID ProfileDarell D. Bigner, David M. Ashley, View ORCID ProfileChristopher J. Pirozzi, Yiping He
doi: https://doi.org/10.1101/2022.11.05.515291
Michael A. Sun
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
3Pathology Graduate Program, Duke University Medical Center, Durham, NC 27710, USA
Rui Yang
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Heng Liu
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
3Pathology Graduate Program, Duke University Medical Center, Durham, NC 27710, USA
Wenzhe Wang
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Xiao Song
4The Ken & Ruth Davee Department of Neurology, Lou and Jean Malnati Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Bo Hu
4The Ken & Ruth Davee Department of Neurology, Lou and Jean Malnati Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Nathan Reynolds
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Kristen Roso
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Lee H. Chen
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Paula K. Greer
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Stephen T. Keir
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
5Department of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA
Roger E. McLendon
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Shi-Yuan Cheng
4The Ken & Ruth Davee Department of Neurology, Lou and Jean Malnati Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Darell D. Bigner
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
5Department of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA
David M. Ashley
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
5Department of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA
Christopher J. Pirozzi
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Yiping He
1The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA
2Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
Posted November 05, 2022.
Repurposing clemastine to target glioblastoma cell stemness
Michael A. Sun, Rui Yang, Heng Liu, Wenzhe Wang, Xiao Song, Bo Hu, Nathan Reynolds, Kristen Roso, Lee H. Chen, Paula K. Greer, Stephen T. Keir, Roger E. McLendon, Shi-Yuan Cheng, Darell D. Bigner, David M. Ashley, Christopher J. Pirozzi, Yiping He
bioRxiv 2022.11.05.515291; doi: https://doi.org/10.1101/2022.11.05.515291
Repurposing clemastine to target glioblastoma cell stemness
Michael A. Sun, Rui Yang, Heng Liu, Wenzhe Wang, Xiao Song, Bo Hu, Nathan Reynolds, Kristen Roso, Lee H. Chen, Paula K. Greer, Stephen T. Keir, Roger E. McLendon, Shi-Yuan Cheng, Darell D. Bigner, David M. Ashley, Christopher J. Pirozzi, Yiping He
bioRxiv 2022.11.05.515291; doi: https://doi.org/10.1101/2022.11.05.515291
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)